Previous studies demonstrated that MELK interacts with and phosphorylates its downstream substrates including FOXM1, eukaryotic translation initiation factor 4B (eIF4B) and SQSTM1, and thus promotes the malignant phenotype of human cancer (34–36). This evidence concerns the gene EIF4B and cancer.